When a large and successful institutional investing company like Alpha Capital Anstalt decides to invest in a certain field, it studies it in depth. The investment is always carefully screened before management gets the green light. Alpha Capital Anstalt investment strategy focuses on diverse but prominent areas, including startup companies,...
Read more
Category Archives: financial
Collaborative Israeli-Palestinian NGO Unites Youthful Entrepreneurs
In spite of the pandemic, Tech2Peace has persisted with a program that aims to forge permanent business partnerships. A global pandemic has not succeeded in stopping an initiative whose objective is to unite youthful Israeli and Palestinian tech fans and entrepreneurs. Tech2Peace, a collaborative Israeli-Palestinian NGO is pushing on with...
Read more
$25 Million Program For Assisting New Startups With Investors
This step is a reaction to the decrease of investments of upcoming startups in Israel in recent years. The IIA (Israel Innovation Authority) declared the start of a new charity program whose objective is to help startups in their inception stage take off, allocating the project NIS 80 million (USD25...
Read more
Evogene to Raise $60 M
Evogene Ltd. (TASE:EVGN) has filed a registration statement with the US Securities and Exchange Commission (SEC) to raise $60 million in a public offering on the New York Stock Exchange. Evogene uses computational genomics technologies to Spritz amount have pharmacy no prescription needed contrasting over-the-counter the face http://tecletes.org/zyf/aciclovir-dosis ok which...
Read more
Compugen’s $500 M Deal With Bayer
Compugen Ltd. (NASDAQ: CGEN) signed a deal worth more than $500 million with Bayer Healthcare. The collaboration and license agreement for the research, development, and commercialization of antibody-based therapeutics for cancer immunotherapy against two novel Compugen discovered immune checkpoint regulators will give Bayer full control over further development and have...
Read more
OrbiMed Invests $5 M in cCam
The OrbiMed Israel Fund has completed a $5 million investment in cCam. cCam’s drug, a monoclonal antibody known as CM-10, is expected to be effective in more than 60 percent of patients eligible for treatment for metastatic melanoma cases CM-10 derives from research suggesting that tumor cells leverage the CEACAM1...
Read more
GE Healthcare Invests $27.5 M in Insightec
Elbit Medical Technologies Ltd. (TASE: EMTC) announced that its subsidiary InSightec Image Guided Treatment Ltd. has signed a memorandum of understanding with GE Healthcare. Under the agreement, GE Healthcare will invest $27.5 million in the company. Insightec develops MRI-guided focused ultrasound devices for the treatment of uterine fibroids, tumors, and...
Read more
cCam Raises $3 M
cCam Medical Ltd. has raised $3 million from Pontifax Ltd. and Mori Arkin’s Arkin Holdings Ltd. $2.5 million will be transferred at the signing and the balance in milestone payments. cCam also extended its cooperation agreement with Hoffmann-La Roche, which has the right to commercialize the company’s technology in exchange...
Read more
Avraham Raises $3 M for Neuro
Avraham Pharmaceuticals has raised $3 million from Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, Pontifax, Clal Biotechnology Industries (CBI), Technion Research and Development Foundation Ltd. (TRDF), Professor Marta Weinstock-Rosin and others. This investment round follows a U.S. $9 million financing in April, 2010. Avraham...
Read more
BrainStorm Gets $1.1 M OCS Grant
BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), has received a grant from Israel’s Office of the Chief Scientist (OCS) for $1.1 million (NIS 3.8 million) . BrainStorm is performing a Phase I/II human clinical trial in Israel with the company’s adult stem cell therapy in patients with ALS, often referred to...
Read more